Abstract
Objective: To present the clinical features and follow-up of a case of anterior uveitis secondary to intravitreal bevacizumab injection. Case Presentation: A 73 year old female patient, under follow-up in our retina unit for neovascular age-related macular degeneration (AMD), presented with complaints of pain and decreased vision in the left eye that started 13 days after an intravitreal bevacizumab injection. On ophthalmologic examination, best corrected visual acuity was 1.5 logMAR in the right eye and 2.3 logMAR in the left eye. Intraocular pressure (IOP) was measured as 20 mmHg in the right eye and 40 mmHg in the left eye. Biomicroscopic examination revealed a normal anterior segment in the right eye, while in the left eye, granulomatous keratic precipitates were observed in the inferoparacentral cornea, along with +3 flare in the anterior chamber. Pseudoexfoliation was present; the pupillary margins were regular, and posterior synechiae were not detected. Dilated fundus examination revealed a scar consistent with senile macular degeneration in the right eye, while the retina appeared hazy in the left eye. Ocular ultrasonography demonstrated an attached retina in the left eye without vitreous reaction. The patient was evaluated as anterior uveitis secondary to intravitreal bevacizumab injection and was hospitalized for follow-up and treatment. Topical corticosteroid and anti-glaucomatous therapy were initiated, leading to regression of findings, and the patient was followed up for 3 months. Conclusion: Anterior uveitis secondary to intravitreal bevacizumab injection is a rare complication. Endophthalmitis should always be considered in the differential diagnosis, and in appropriate cases, successful outcomes can be achieved with topical corticosteroid therapy. Keywords: Anti-vascular endothelial growth factor (anti-VEGF), anterior uveitis, bevacizumab, intraocular inflammation

This publication has 11 references indexed in Scilit: